Eli Lilly and Co (NYSE:LLY) shares are trading higher on Friday. The company plans to start selling its obesity drug through a new approach aimed at expanding access.
Wall Street staged a sharp rebound Friday after a bruising week of volatility in tech, as a wave of dovish comments from Federal Reserve officials flipped market expectations toward a rate cut next month.
Bank of America maintains Neutral rating on Gap but boosts EPS estimates for FY25 and FY26 after better-than-expected Q3 results and holiday season margin projections.